Provide evidence based therapeutic pathways to oncology practices.
Our Business
KEW is commercializing the industry’s first personalized oncology care practice management solution for community oncologists whether they are embedded in a hospital or as independent practicing units. The KEW Oncology Network provides comprehensive, evidence based proprietary treatment pathways that include conventional treatments as well as information about genetics/genomic based treatments. KEW is establishing a CLIA laboratory in Cambridge, MA that will be ready to accept samples for comprehensive cancer gene testing and interpretation services.
Our Goals
- To develop and make available easily navigable, comprehensive Therapeutic pathways (KEW TPx) that can be deployed for use by Community oncology practitioners around the U. S.
- Deploy the KEW TPx and make available to members of the KEW Oncology Network.
- Provide comprehensive DNA based genetic testing of patient tumor samples (from formalin fixed, paraffin embedded, FFPE) and interpretation services
- Assemble integrated data sets that include clinical information, outcomes information and cost information from members of the KEW Oncology Network